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This literature review focuses on both medicinal and therapeutic treatment 
options for Conduct Disorder and Antisocial Personality Disorder. Conduct 
Disorder is considered a precursor to Antisocial Personality Disorder, and 
research on the treatment of both of these disorders suggests that early 
intervention, during childhood and adolescence, is the most promising treatment 
option for people diagnosed with Conduct Disorder. Medicinal treatments for 
Conduct Disorder that are discussed within this literature review are lithium, 
methylphenidate, and risperidone, while the therapeutic treatments reviewed are 
parent management training and cognitive-behavioral therapy. Less encouraging 
research results have been found for the treatment ofAntisocial Personality 
Disorder, but this review will discuss risperidone and quetiapine as researched 
medicinal treatments and residential treatment facilities as a therapeutic 
treatment for the disorder. In all areas of treatment research, further studies are 
needed to determine treatment efficacy. 
The DSM-IV TR (2000), published by the 
American Psychiatric Association, is a widely-
recognized source used by mental health 
professionals to classify mental disorders. Created 
for diagnostic purposes, it includes descriptions of 
each disorder categorized under the headings of 
Diagnostic Features, Associated Features and 
Disorders, Prevalence, and Differential Diagnosis. In 
consulting the manual, it becomes readily apparent 
that one crucial component of each disorder is 
lacking: treatment options. This literature review will 
discuss that missing component for two disorders:  
Conduct Disorder (CD) and Antisocial Personality 
Disorder (APD). The reason for exploring these 
disorders together is that CD is viewed as an 
antecedent to APD, and therefore timing of 
treatment becomes a factor while considering 
treatment options. Before delving into specific 
treatments for these two disorders though, it is 
necessary to familiarize one with the actual disorders 
and their symptoms, since treatments typically aim to 
reduce disorder symptomology. For purposes of 
clarity and comprehension, the disorders will be 
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discussed in terms of the aforementioned categories 
taken from the DSM-IV TR. 
CD is a Disruptive Behavioral Disorder that has 
three main diagnostic criteria. Criteria A is that the 
person in question repetitively behaves in a way that 
violates the basic rights of others or age-appropriate 
societal norms. These violations are separated into 
four groups: aggression that causes harm to or 
threatens other people or animals, nonagressive 
behavior that results in property loss or damage, 
deceitfulness or theft, and serious rule violations. In 
order to be diagnosed with CD, three or more of 
these characteristics must have been present within 
the last year, with one of the characteristics present 
within the last 6 months (DSM-IV-TR, 2000). 
Criteria B states that the person exhibits 
disturbances in behavior that lead to significant 
impairments in his or her academic, social, or 
occupational functioning. Criteria C clarifies that a 
person may be diagnosed with CD after age 18, but 
only if a diagnosis ofAPD cannot be given. There 
are two onset types of CD: Childhood-onset and 
adolescent-onset. The main differences between the 
two onset types are that the childhood-onset type is 
diagnosed before age 10, whereas the adolescent-
onset type is diagnosed after that age, and those in 
the childhood-onset group are usually male, show 
more aggression, and are more likely to develop 
APD later in life as compared to older onset group 
(DSM-IV-TR, 2000). 
In terms of associated features, the DSM-IV-TR 
(2000) indicates that those with CD typically lack 
empathy or concern for others, and often 
erroneously view the intentions of others as 
malicious. Also, these people may be more likely to 
take part in risky behavior, such as engaging in 
sexual behavior at a young age, drinking, and using 
illegal substances. Oftentimes, those with CD are 
found to have Attention-Deficit/Hyperactivity 
Disorder (ADHD), or other Learning, Anxiety, or 
Mood Disorders (DSM-IV-TR, 2000). In 
examining general population studies, prevalence 
rates range from 1 to 10%, with the disorder being 
more widespread among males. This disorder is 
distinguished from Oppositional Defiant Disorder 
(ODD) by the persistent violation of age-
appropriate societal norms and the rights of others.  
If criteria for both disorders are met, only the CD 
diagnosis is given. ADHD and CD are different in 
that those with both CD and ADHD may be 
impulsive, hyperactive, and disruptive, but those with 
only ADM) do not typically violate age-appropriate 
norms like those with CD. When criteria for both of 
these disorders are met, both diagnoses are given 
(DSM-IV-TR, 2000). 
Antisocial Personality Disorder, with which many 
people with child-onset Conduct Disorder are later 
diagnosed, is a serious and rarely diagnosed 
personality disorder. The main characteristic ofthis 
disorder is a pervasive pattern of disregard for and 
violation of the rights of others. This behavior begins 
in childhood or adolescence, and follows the person 
into adulthood. The two other criteria for the 
diagnosis of this disorder are that the person must be 
at least 18 years of age to be diagnosed and he or 
she has to have shown some symptoms of CD 
before age 15. The four behavioral categories that 
apply to a CD diagnosis, as described above, also 
apply to that of an APD diagnosis (DSM-IV-TR, 
2000). People with APD tend to be irresponsible 
and highly critical of others, while they are generally 
non-remorseful for wrongdoings that they commit. 
Some other associated features of the disorder are 
impulsivity, cockiness, superficial charm, and 
promiscuity. People with this disorder oftentimes 
meet the criteria for other Personality Disorders such 
as Borderline, Histrionic, and Narcissistic 
Personality Disorders. They also have a high 
likelihood of being diagnosed with Anxiety 
Disorders, Substance-Related Disorders, and 
Depressive Disorders. The prevalence of this 
disorder is approximately 3% in males and 1% in 
females, but the disorder has been shown to lessen 
in symptomology as the diagnosed individuals grow 
older, with a noticeable reduction specifically by 
their fourth decades (DSM-IV-TR, 2000). 
In cases ofthe APD diagnosis, it can be difficult 
to discern this disorder from other Personality 
Disorders. People with both APD and Borderline 
Personality Disorder display manipulation, but the 
difference lies in their motives. People with APD are 
manipulative for power, money, or other material 
objects, whereas people with Borderline Personality 
Disorder are manipulative to gain attention and 
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nurturance. Additionally, people with APD show 
more aggression and emotional instability than 
people with Borderline Personality Disorder. People 
with both an APD diagnosis and a Histrionic 
Personality Disorder diagnosis tend to be impulsive, 
superficial, reckless, and manipulative, whereas 
people with only Histrionic Personality Disorder do 
not generally exhibit antisocial behavior. Lastly, 
people with both APD and Narcissistic Personality 
Disorder are stubborn, superficial, and 
unempathetic. The difference between the two 
disorders is that those with only Narcissistic 
Personality Disorder are not impulsive, aggressive, 
or deceitful, but they are needier ofthe attention of 
others than those with APD (DSM-IV-TR, 2000). 
The fact that CD and APD share many of their 
symptoms suggests that they are very similar 
disorders. However, a review of the literature on the 
treatments of each of these disorders suggests that 
they have one major difference. The difference that 
becomes evident is that there are many more 
treatment options for CD than there are for APD, 
suggesting that it is much easier to treat the 
symptoms when they first surface, during the early 
stages of CD. This literature review focuses on 
examining both medicinal and therapeutic treatments 
for CD and APD. Medicinal approaches in treating 
CD that will be discussed are lithium, 
methylphenidate, and risperidone. These 
medications are not used to treat CD in its entirety, 
since it is so pervasive in nature, but instead are used 
for curtailing specific symptoms of CD. Therapy, 
however, does consider CD as a whole disorder, 
and works to improve all problematic elements 
within the disorder. This literature review will discuss 
parent management training and cognitive-behavioral 
therapy as two therapeutic options for CD. For 
APD treatments, the scope of previously conducted 
research is narrower, but medicinal options such as 
risperidone and quetiapine will be discussed as 
thoroughly as possible, as well as residential 
treatment facilities as a therapeutic treatment 
technique. 
In considering CD and APD, especially in terms 
of their prevalence rates being so low, one may 
wonder why this area of psychology deserves 
immediate attention. It must be recognized though 
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that APD, in addition to being a serious personality 
disorder, is also considered an equally serious social 
threat. Within prison settings, up to 75% of inmates 
are likely to meet an APD diagnosis, which holds the 
harrowing implication that people with APD are at 
high risk of committing serious criminal offenses 
(Hare, 1996 as cited in Reid, & Gacono, 2000). 
They are estimated to be responsible for over 50% 
of the serious crimes committed, and a 1992 study 
by the FBI found that 44% of the people 
responsible for killing an officer on duty had APD 
(Walker, Thomas, & Allen, 2003). These statistics 
paint a more powerful picture than the low 
prevalence rates ofAPD do, and illustrate the 
importance of treating CD before it evolves into an 
APD diagnosis. 
Conduct Disorder 
Medicinal Treatments for Specific Isolated 
Symptoms of CD 
Lithium in treating aggression. Since CD has a 
wide range of symptoms, treatment providers often 
aim to reduce or eliminate the most severe 
symptoms first. One of these targeted symptoms is 
maladaptive aggression, which is considered serious 
in that it usually leads to some personal loss ofthe 
patient, the patient's family, and/or society (Steiner, 
Saxena, & Chang, 2003). Usually, pharmacologic 
treatment is given to CD patients only in cases when 
this type of overt aggression is the chief symptom of 
their disorder (Gerardin, Cohen, Mazet, & Flament, 
2002). Since aggression is considered a normal and 
useful survival tool, physicians never aim to eliminate 
this characteristic in their patients. Instead, they 
attempt to shape it into a more adaptive 
characteristic. Because ofthe separation that exists 
between maladaptive and adaptive aggression, any 
aggression that a person with CD exhibits must be 
viewed in its context. An example of maladaptive 
aggression would be if a child walked over to 
another child unknown to him or her, and punched 
him or her in the face. This is maladaptive because 
the victimized child did nothing to elicit the abuse 
that he or she endured. An example of adaptive 
aggression would be if a child punched a perpetrator 
who was attempting to hurt his or her sibling. The 
child's reaction would then be seen as adaptive 
because it is a protective mechanism (Steiner, 
Saxena, & Chang, 2003). 
One pharmacologic treatment that has been 
repeatedly tested to combat maladaptive 
aggressiveness in children and adolescents with CD 
is lithium carbonate (Malone, Delaney, Luebbert, 
Cater, & Campbell, 2000), which is a mood 
stabilizer used to control aggression in manic-
depressive patients (Gerardin et al., 2002). Although 
there is no licensed drug for treating CD, lithium is 
the most documented drug treatment for the 
disorder (Gerardin et al., 2002). Lithium was found, 
by Malone et al. (2000) to be a safe and effectual 
short-term treatment for aggression in children and 
adolescents with CD diagnoses. In this study, the 
Overt Aggression Scale (OAS) was used to 
measure aggression before and after lithium 
administration. Using this scale as a measurement 
tool, the researchers discovered that there was a 
statistically significant reduction in overt aggressive 
behavior of those with CD who received 4-weeks 
of lithium treatment in comparison to those who 
received the placebo. Sixteen of the 20 lithium 
recipients responded positively to lithium, whereas 
only 6 of the 20 placebo recipients responded 
positively to their treatment (Malone et al., 2000). 
Although some studies conducted on lithium 
effectiveness show a decrease in subject aggression, 
many other studies show no such result. In studies 
by Carlson, Rapport, Patakai, and Kelly (1992), 
Klein (1991b), and Rifkin et al. (1997), no 
significant difference was found between subjects 
who were given lithium versus those who were given 
the placebo (Mpofu, 2002). Some possible 
explanations for these contradictions, aside from 
lithium producing inconsistent results, are that the 
samples from each of these studies drastically 
differed in terms of ages of the subjects and the type 
of patient being treated (inpatient vs. outpatient) 
(Mpofu, 2002). Additionally, the sample size of 
many of the lithium studies was too small for their 
results to be generalized (Weller, Rowan, Weller, & 
Elia, 1999). Researchers have generally accepted 
the idea that the usefulness of lithium in treating 
aggression is in need of further testing (Mpofu, 
2002). 
Methylphenidate in treating aggression and 
impulsivity. Methylphenidate (MPH), a 
psychostimulant, has also been tested as a possible 
CD-symptom reliever. There is a long history of 
psychostimulant use in the treatment of behavioral 
disorders. It is likely that research will continue in 
this area and that psychostimulants will remain the 
first choice of physicians in the treatment of CD 
(Mpofu, 2002). Klein et al. (1997, as cited in 
Shreeram & Kruesi, 2000) studied the effects of 
MPH on 84 children with CD and found that the 
medication group was superior to the placebo group 
in minimizing CD symptom ratings. Kaplan et al. 
(1990, as cited in Shreeram & Kruesi, 2000) 
studied the effects of MPH on male conduct-
disordered adolescents, and found that it significantly 
reduced physical aggression in the subjects. In 
addition to decreasing aggression, Connor, Barkley, 
and Davis (2000) found that their subjects 
responded less impulsively to certain tasks after 
being treated with MPH, though no placebo 
comparison was made in this study. Furthermore, 
these researchers found that MPH usage decreased 
CD-symptom severity, as measured before and after 
treatment on the Disruptive Behavior Scale (DBS). 
Contradicting these positive results though are 
results from studies like that of Pelham et al. (1991, 
as cited in Shreeram and Kruesi, 2000), in which 
researchers found a response rate of only 50% to 
MPH. 
Risperidone in treating aggression and 
impulsivity. Another medication frequently used to 
decrease aggression in CD patients is risperidone, 
an atypical antipsychotic (Findling, McNamara, 
Branicky, Schluchter, Lemon, & Blumer, 2000). 
This medication is unique in that many older children 
and adolescents who exhibit aggression and have 
not responded to other medications have responded 
to risperidone (Fras & Major, 1995; Schreier, 
1998, as cited in Shreeram & Kruesi, 2000). Ercan, 
Kutlu, Cikoglu, Veznedaroglu, Erermis, and Varan 
(2003) and Findling et al. (2000) found that even 
with small doses of risperidone (as little as .25 mg/ 
day), aggression in children and adolescents with 
CD was decreased. Ercan et al.'s (2003) study is 
especially notable in that the researchers included 
only subjects who were considered to have severe 
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CD, which was determined by high scores on both 
the aggression and delinquency subscales ofthe 
Child Behavior Checklist (CBCL). In this study, 
improvement in subjects was measured using the 
Clinical Global Impression (CGI) scale, which 
ranges from 1 to 7, 7 demonstrating the most severe 
manifestation of CD symptoms. At the start of the 
study, the mean CGI rating for the sample of21 
children and adolescents was 6.4. After 8 weeks of 
risperidone treatment, this rating shifted to a 3.2. 
The symptom of CD that seemed to decrease most 
in this study was aggression, but there were also 
significant decreases found in the impulsivity of the 
subjects (Ercan et al., 2003). Findling et al. (2000) 
compared their medication group to a placebo 
group, and found that the treatment group showed 
improvements on nearly all measures of aggressive 
behavior, whereas the placebo group failed to 
demonstrate such improvements. Although these 
studies seem to suggest that risperidone may be an 
effective treatment for aggression and other CD 
symptoms, limitations like subject attrition (Findling 
et al., 2000), and lack of double-blind placebo-
controlled designs (Ercan et al., 2003) still leave 
questions about the effectiveness of risperidone. 
Dangers of medicinally treating CD 
symptoms. Even if a medication is deemed in the 
future as a successful treatment for CD symptoms, it 
is necessary to weigh the medication's consequences 
against its actual benefits. Forming the bulk of these 
consequences are the side effects of the medication. 
Even the medications currently being tested for their 
effectiveness in treating CD symptoms have a list of 
side effects attached to them. Lithium, for instance, 
although seemingly helpful in reducing aggression in 
some CD patients, has been known to produce 
cognitive dulling, weight gain, enuresis (Weller et al., 
1999), sedation, fine tremor, hypothyroidism, and 
leukocytosis (Mpofu, 2002). Psychostimulants, like 
methylphenidate, have side effects like loss of 
appetite, insomnia, nervousness, abdominal pain 
(Shreeram, & Kruesi, 2000), dependency, social 
withdrawal, and psychosis (Mpofu, 2002). With 
risperidone and other antipsychotic medications, 
side effects such as weight gain, sedation, anxiety 
(Shreeram, & Kruesi, 2000), and orthostatic 
hypotension (Mpofu, 2002) have been noted. Even  
potentially fatal side effects, such as fluctuating vital 
signs and neuroleptic malignant syndrome have been 
associated with antipsychotic use in the pediatric age 
group (Shreeram, & Kruesi, 2000). Because of the 
gravity of some of these side effects, physicians may 
want to reconsider using medication for CD unless 
they feel confident that the benefits will outweigh the 
negative effects. 
Therapeutic Treatments for Conduct Disorder 
Parent management training. Parent 
management training (PMT) is the most thoroughly 
investigated therapeutic technique for children and 
adolescents with CD (Kazdin, 2003). Behavioral 
methods, such as PMT, have been researched 
extensively over the last 30 years, and this research 
history has resulted in many clinicians' respect for 
these techniques (Hutchings, Lane, & Kelly, 2004). 
Many support this type of therapy because there is a 
belief that aggression and other behavioral problems 
are developed and inadvertently reinforced in the 
home by maladaptive interactions between parents 
and their children (Kazdin, 2003). This belief is 
supported by research that has highlighted parenting 
variables as factors linked with antisocial behavior 
early in life, as well as subsequent delinquency 
(Campbell, 1995; Loeber & Jay, 1994; Patterson, 
Reid, & Dishion, 1993; Reid, 1993, as cited in 
Hutchings, et al., 2004). Therefore, PMT has been 
designed to make parent-child interactions more 
positive. 
PMT has been studied in connection with 
children and adolescents ranging from ages 2 to 17, 
and these studies have included a wide range of 
conduct problem severity within their subjects 
(Kazdin, 2003). One subtype of PMT, known as 
Parent-child interaction therapy (PCIT) has been 
tested on children as young as preschoolers who 
display early behavioral problems (Nixon, Sweeney, 
Erickson, & Touyz, 2004). PCIT is based on Hanf's 
(1969) model of parent-training (as cited in 
Sheldrick, Kendall, & Heimberg, 2001) and was 
designed to teach parents how to play positively 
with their children and interact with them in a way 
that will modify unwanted behavior. It also presents 
parents with precise behavior management 
strategies, such as clarifying instructions to their 
children, and punishing them appropriately for their 
7 
misbehavior (Nixon et al., 2004). Nixon et al. 
(2004) found that PCIT was more effective than 
non-treatment in improving the behavior of conduct-
disordered preschoolers, and that this positive effect 
could still be seen in most of the children two years 
after the therapy ended. This study differs from other 
studies conducted on PCIT because it followed the 
subjects for a considerable amount of time after 
therapy, whereas other studies have only illustrated 
the short-term benefits of PCIT (Eyberg et al., 
2001; Funderburk et al., 1998, as cited in Nixon et 
al., 2004). However, Nixon et al. (2004) failed to 
include a comparison group in their follow-up 
measurements, so it is unclear ifthe lasting behavior 
improvements were due to the treatment, or to 
another factor, such as subject maturation (Nixon et 
al., 2004). 
PMT, in comparison to PCIT, is a more 
structured and comprehensive type of instructional 
therapy. It is based on the social learning theory, and 
integrates the concepts of time-out, positive 
reinforcement, and contingency contracting into 
treatment (Kaalin, 1993 as cited in Hutchings et al., 
2004). Explicit booklets have even been developed 
describing how to implement PMT for different age 
groups. The skills taught in this type of therapy can 
reach parents through a variety of mediums: through 
the therapist meeting with one or both parents, or 
through the therapist providing the parent(s) with 
informational videos (Frick, 2001). Although each of 
these variations has been shown in different studies 
to have a positive effect on conduct-disordered 
children, meeting with both parents seems to be 
most effective (Webster-Stratton, & Hammond, 
1997; Webster-Stratton et al., 1988, 1989 as cited 
in Farmer, Compton, Burns, & Robertson, 2002). 
The informational video option provides an 
alternative for parents who cannot afford many 
therapy sessions. Research on these videos indicates 
that they can be effective in behavior control of 
children, however they do not seem to be as helpful 
as face-to-face meetings between the parents and 
the therapist (Farmer et al., 2002). 
PMT is based around the idea that parenting 
styles that include nagging, inconsistent discipline, 
ineffective punishments, and minimal positive 
parental involvement play a significant role in the  
development and maintenance of childhood 
behavioral problems. The PMT design specifically 
targets these characteristics within parent-child 
interactions and attempts to obliterate them and 
replace them with more effective approaches 
(Hutchings et al., 2004). In the office, PMT 
combines sessions where the therapist meets with 
the parent(s) alone to teach them various parenting 
skills with sessions where the child is present for the 
parent(s) to practice their learned techniques on. 
PMT sessions teach parents about different stages 
of child development and how they should treat their 
children during each stage to assist them in 
developing a positive social-emotional identity 
(Mabe, 2003). Therapists teach parents how to 
extinguish any antisocial characteristics their children 
may exhibit, and how to replace these characteristics 
with prosocial ones through positive reinforcement. 
Parents are advised on how to structure their 
interactions with their children by setting limits, 
responding appropriately to their children's' negative 
emotions, and communicating their requests to their 
children effectively (Mabe, 2003). Also, parents 
learn what types of disciplinary action work best in 
behavior control, and how to time their discipline to 
make it more successful. This forces parents to see 
their children's behavior in a broader context, and 
provides a practical conceptualization of what effect 
the familial environment can have on a child's 
behavior (Frick, 2001). By adopting this social-
ecological stance on behavior, parents begin to 
recognize that many factors and systems (like the 
child's home and school system) come together to 
influence their child's behavior. Recognizing this can 
help parents see the need for their inclusion in their 
child's treatment (Borduin, 1999). 
Hutchings et al. (2004) conducted a four-year 
follow-up study comparing two types of PMT for 
41 2-10 year-olds. One type was a standard form 
of PMT, while the other was an intensive form. The 
intensive form differed from the standard in that it 
lasted for 25 hours instead of only 7 hours, and it 
gave parents a chance within therapy to practice 
what they were being taught, and directly experience 
the success of their newly acquired skills. This study 
found that both forms of PMT were successful in 
reducing conduct problems in the children, but that 
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the intensive form elicited a more significant and 
lasting change. This adds to the evidence base that 
therapy involving parental training and rehearsal of 
child-management techniques has a better outcome 
than more didactic and less interactional types of 
therapy, where parents do not experience as much 
collaboration with the therapists. Also, the 
researchers found that the therapy administered in 
this study had a more noticeable effect in the 
younger children, suggesting that the earlier the 
intervention, the more successful it is (Hutchings et 
al., 2004). 
Cognitive-behavioral therapy. Another therapy 
used for treating CD is cognitive-behavioral therapy 
(CBT), a form developed by Beck et al. (1979) and 
Ellis (1962) (both cited in Broota, & Sehgal, 2004). 
Since CD falls under the umbrella of Disruptive 
Behavioral Disorders, CBT aims to help clients 
control their behavior by becoming aware of their 
thought processes before reacting to situational cues. 
Studies on the perceptions of conduct-disordered 
children show that these children differ from children 
without CD in the way that they interpret their 
environments (Van de Weil et al., 2002). Conduct-
disordered children are more likely to selectively 
direct their attention towards hostile social cues, 
therefore heightening the likelihood that they will 
respond in an aggressive manner to their 
environments (Van de Weil et al., 2002). Even in 
ambiguous situations, children with CD tend to 
interpret situations as threatening to them, showing a 
deficit in their social cognition (Frick, 2001). They 
are also less likely than children without CD to 
spawn solutions to social problems (Van de Weil et 
al., 2002). 
CBT is designed to lead children through 
exercises that encourage them to encode and 
interpret all situational cues, and to formulate and act 
upon situation-appropriate goals (Van de Weil et al., 
2002). CBT, like PMT, uses a skills-building 
approach, but CBT works predominantly with 
children as opposed to parents. Moreover, most 
CBT programs are designed to accommodate 
clients in group settings (Frick, 2001). Although 
children do not get as much individual attention when 
combined with other children, group-based skills 
training sessions such as these have at least two  
important benefits. First, group meetings are more 
economical than individual meetings for clients. 
Second, group-based skills training has been shown 
in numerous studies (Cavell, & Hughes, 2000; 
Beelman et al., 1994; Kavale, Mathur, Forness, 
Rutherford, & Quinn, 1997; Schneider, 1992, as 
cited in Ang, & Hughes, 2002) to produce larger 
benefits than individual-based skills training. 
Something interesting to note about this group setting 
though is that in many of these studies, it was found 
that conduct-disordered children improve more 
behaviorally when they are mixed in groups with 
children who do not have CD, instead of being 
treated in a group consisting only of children with 
CD or antisocial behavior (Ang, & Hughes, 2002). 
Therapists administering CBT play a very active 
role in the treatment process by modeling the skills 
they are teaching, providing prompts for certain 
behaviors, role-playing with the children, and 
providing feedback and praise when the children use 
skills appropriately (Frick, 2001). Many CBT group 
programs also incorporate a token economy into 
their treatment plan, because it fits with the theme of 
operant conditioning and has also shown signs of 
being effective in improving the behavior of non-
responsive youth with CD (Field, Nash, Handwerk, 
& Friman, 2004). In CBT, therapists attempt to 
convey genuineness to their clients, so their clients 
will trust them, hopefully leading to them being less 
resistant to change. Also, anger management and 
emotion control are two topics that are extensively 
addressed within therapy (Broota, & Sehgal, 2004). 
Broota and Sehgal (2004) performed a study 
including 80 children with discipline and conduct 
problems where they compared results from four 
treatment groups: CBT treatment only, parental 
counseling only, CBT plus parental counseling, and 
unrelated conversation only (the control group). Pre-
and post-treatment, they took measurements of 
factors such as childhood psychopathology, anger 
expression, and parental discipline, and across all of 
their measurements, there was a significant positive 
change in all three of the treatment groups. Although 
they found CBT to be an effective treatment in 
comparison to the control group, the treatment that 
yielded the best results was CBT plus parental 
counseling, suggesting that the solution to treating 
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CD may lie in attacking it from all different angles at 
once (Broota, and Sehgal, 2004). Rohde, Clarke, 
Mace, Jorgensen, and Seeley (2004) did not find 
CBT to have such a positive effect on CD in their 93 
adolescent subjects though. They studied CBT in 
relation to adolescents who were diagnosed with 
comorbid Major Depressive Disorder (MDD) and 
CD, and found that the therapy reduced MDD 
symptoms, but did not have an effect on the course 
of CD during or post-treatment. One possible 
explanation for this is that the form of CBT 
administered to the subjects was tailored in some 
ways to reducing MDD symptoms, so this may have 
taken away from any treatment components that 
could have positively affected CD symptoms 
(Rohde et al., 2004). 
Limitations to CD therapy and research on 
therapeutic treatment. The most common therapy-
related problem is that between 40-60% of people 
who begin therapy do not complete treatment 
(Wierzbicki & Pekarik, 1993 as cited in Kazdin, 
2003). Despite therapists' best efforts to make 
sessions as engaging as they can for parents, client 
drop-out rates are an especially prevalent problem 
with PMT treatment (Frick, 2001). Miller and Prinz 
(2003) specifically set out to study engagement of 
families in the treatment of childhood conduct 
disorders, and identified different possibilities for 
why parents may truncate PMT treatment. They 
found that families that completed treatment were 
more likely to have approached treatment with 
internal expectations, believing that treatment would 
address issues within the family, such as parenting 
style. In contrast, those parents who dropped out of 
treatment were more likely to have demonstrated 
external expectations of treatment, believing that the 
treatment would focus more on the child and his or 
her behavior. These latter parents may have felt that 
treatment was not focusing enough on what they 
considered to be the root of the problem, or in other 
words, their child's behavior. This idea implies that 
therapy style is not the only factor that influences 
treatment outcome. Also important are the attitudes, 
attributional styles, and motivations ofthe parents 
involved (Miller, & Prinz, 2003). 
Another problem with the research on PMT 
effectiveness is that although it seems beneficial, it 
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has not been studied in direct comparison to other 
therapies. Therefore, researchers and clinicians have 
failed to determine if PMT is superior to other forms 
of therapy used to treat CD (Van de Wiel, Matthys, 
Cohen-Kettenis, & Van Engeland, 2002). Although 
PMT has supportive research results on its side, 
something to consider is that researchers and 
therapists have yet to fully understand the mediating 
factors for its success, which does not bode well for 
improving what is already being practiced 
(Remshmidt, 2003). Another barrier to PMT 
treatment was identified in a study conducted by 
Kazdin and Wassell (1999). These researchers 
considered demographic factors that may play a role 
in how receptive children are to PMT treatment, and 
found that socioeconomic disadvantage, parental 
stress, and parental psychopathology predicted 
inferior treatment outcomes (Kazdin, & Wassell, 
1999). This shows that factors external to treatment 
may also have to be addressed within treatment for 
any type of behavior resolution to be reached. 
In terms of CBT research, most studies 
addressing this issue lack follow-up measurements, 
so the long-term effect of this treatment type remains 
undetermined. Also, CBT seems to work best with 
older children and adolescents than with younger 
children, perhaps indicating that a person may need 
to be at a certain stage in his or her cognitive 
development before being exposed to CBT (Van de 
Weil et al., 2002). Many times therapists encounter 
difficulty in getting their clients to practice the skills 
they are taught outside of treatment, in their normal 
environments, which may negatively impact the 
endurance of this treatment (Frick, 2001). 
Antisocial Personality Disorder 
Medicinal treatment for specific isolated 
symptoms of Antisocial Personality Disorder 
Since APD is a personality disorder, and 
personality is a relatively stable characteristic, there 
is not much evidence that medicine helps in treating 
the disorder. Because of the low prevalence of 
APD, most published research on medicinal 
treatments for the disorder has been in the form of 
case studies. One very successful case study 
conducted by Hirose (2001) focused on a 32-year- 
old man who was hospitalized for severe APD. After 
receiving 3 mg/day of risperidone, he experienced a 
noticeable reduction in aggression and impulsivity, 
and for the first time in his life, was able to maintain a 
job (Markovitz, 2004). These results cannot be 
generalized though because only one person was 
treated, and treatment success of this kind is very 
rare with APD. Walker, Thomas, and Allen (2003) 
studied the effect that quetiapine, an atypical 
antipsychotic, would have on treating impulsivity, 
aggressiveness, and irritability inAPD patients. They 
found that quetiapine was successful in reducing 
these characteristics in the APD patients, and it did 
so with very few side-effects. However, this study 
only included 4 subjects and long-term effects were 
not measured, which limits the reliability ofthe 
results. Additionally, even if quetiapine is labeled in 
the future as an empirically supported treatment for 
APD, very few treatment facilities (especially prisons 
and jails, where most people with APD are treated) 
will have the funds necessary to dispense this 
treatment (Walker, Thomas, & Allen, 2003). 
An issue that often arises while attempting to 
medicinally treat APD is that many patients with an 
APD diagnosis are drug-seeking, and have a history 
of drug abuse. This poses a problem because they 
tend to reject drugs that do not produce a euphoric 
effect, and often seek out drugs that they have been 
addicted to in the past, instead of ones that actually 
help any APD symptoms they are exhibiting 
(Walker, Thomas, & Allen, 2003). 
Residential Treatments of Antisocial Behavior 
and Antisocial Personality Disorder as a Whole 
Although APD is defined in the above 
introduction, it is important also to define antisocial 
behavior more generally. In providing this definition, 
we are recognizing that a person who demonstrates 
antisocial behavior does not always go on to 
demonstrate all criteria necessary to meet an APD 
diagnosis. Antisocial behavior can most simply be 
defined as behavior that lacks empathy or regard for 
others, as well as a distinct inability to adjust to 
behavioral norms and expectations, which are 
usually standardized by society (Frankfort-Howard, 
& Romm, 2002). To help clarify the distinction 
between antisocial behavior andAPD, antisocial  
behavior can be viewed as a symptom of both CD 
andAPD, but even if a child or adolescent with CD 
displays antisocial behavior, he or she cannot be 
diagnosed with APD until after age 18. Additionally, 
antisocial behavior, as defined above, is only one of 
the many diagnostic criteria for APD (DSM-IV TR, 
2000). 
For those children who display antisocial 
behavior and are left untreated, the risk of being 
diagnosed later in life with APD is rather high. It is 
estimated that 40 to 50% of these children will go on 
to become antisocial adults (Robins, 1966, as cited 
by Frankfort-Howard, & Romm, 2002). This 
statistic implies that antisocial behavior is an urgent 
social issue, yet there are very few noteworthy 
solutions to this problem (Wong, 1999). To reduce 
these numbers of what Caspi and Moffitt (1995, as 
cited in Frankfort-Howard, & Romm, 2002) refer 
to as "life course persistent" cases of antisocial 
behavior, residential treatment programs are 
oftentimes recommended, or in criminal cases, 
required by law. Many clinicians believe that this 
type of environment provides the secure and 
controlled atmosphere necessary to facilitate 
behavioral change (Wong, 1999). These programs 
are specifically designed to target the pervasive 
nature of antisocial behavior, and may include 
components such as school courses, occupational 
training, and social skills assistance. In addition to 
these offerings, residential treatment facilities usually 
include some combination oftherapeutic activities, 
such as individual or group counseling, family 
counseling, community meetings, cognitive and 
behavioral programs, volunteer activities, and 
tutoring (Frankfort-Howard, & Romm, 2002). 
These programs, which are often referred to as 
multisystemic or multiple system therapy (MST) 
programs, have been reported by many clinicians as 
the most successful preventative treatment options 
for APD (Reid, & Gacono, 2000). Unfortunately, 
although deemed "most successful," these programs 
often prove too costly for the modest benefits they 
produce (Wong, 1999). 
Although many residential programs have been 
designed to decrease the prevalence of life persistent 
antisocial behavior and APD, research about their 
effectiveness is limited. One reason for this limited 
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scope is that a longitudinal study, the type of study 
that would most clearly and thoroughly illustrate the 
effects of residential treatment centers, is very costly 
and funding is lacking for well-designed studies of 
this type. In addition to this, many ofthe studies that 
have been conducted are flawed by methodological 
problems including nonexistent control groups to 
compare results to, debatable rater subjectivity, and 
differences in outcome definition and measurement 
(Curry, 1991 as cited in Frankfort-Howard, & 
Romm, 2002). Many studies also include a sample 
size too small to generalize the results found 
(Messina, Wish, Hoffman, & Nemes, 2002). There 
have also been problems in understanding and 
replicating components within treatment facilities that 
may be useful, because many studies that focus on 
treatment outcome fail to provide in-depth 
descriptions of treatment procedures and client 
characteristics (Wong, 1999). These issues make it 
difficult to move forward in terms of improving 
treatment, because there is such little evidence of 
what has worked in the past, and if any evidence of 
that sort does exist, it is difficult to determine why 
those certain treatments were effective. 
Research results in this area vary, but much of 
what has been found does not allude to promising 
outcomes for children who display antisocial 
behavior. For example, Knapp, Schwartz, and 
Epstein (1994, as cited in Frankfort-Howard, & 
Romm, 2002) conducted a five-year longitudinal 
study on male delinquents that had been released 
from a Michigan residential treatment program. They 
found that 20% ofthe sample was sentenced to 
adult prisons, the majority ofthis group being 
imprisoned within three years of their release from 
treatment. Amore descriptive study (Asarnow, 
Aoki, & Eslon, 1996, as cited in Frankfort-Howard, 
& Romm, 2002) focused for four years on 51 boys 
who had previously been released from residential 
treatment programs. This study was aimed at 
determining the likelihood ofthese boys being 
admitted to another treatment facility after being 
released from their previous one. In this study, 
researchers found that 32% of this group was at risk 
for out-of-home treatment by the end of their first 
year, 53% by the end of their second year, and 59% 
by the end of their third year out of their residential  
treatment programs. It was also discovered that 
82% of these boys needed special education 
services post-treatment, as well as 57% of them 
needing out-patient therapy. These results suggest 
that delinquent and antisocial young people show a 
need for long-term treatment options in order to 
decrease recidivism and continuation of maladaptive 
behaviors (Frankfort-Howard, & Romm, 2002). 
Generally, the most optimistic research suggests 
that inpatient programs that treat young antisocial 
offenders for a year or longer are more effective 
than ones attempting to treat antisocial adult 
offenders (Reid, & Gacono, 2000). However, 
Kazdin's 1989 study (as cited in Wong, 1999) 
reported optimistic findings after just 2 to 3 months 
of inpatient psychiatric care. Using behavior 
checklists and clinical inventories before treatment 
and comparing them to the same measurements one 
month, one year, and two years after the treatment, 
Kazdin found that there were statistically significant 
improvements on nearly all ofthe clinical measures, 
especially measures that indicated reductions in 
aggressive and hostile behavior (Wong, 1999). 
While treatment options for antisocial behavior 
on its own appear to lack consistency and promise, 
options forAPD are even less encouraging. Most 
treatment designed to target this disorder focus on 
specific behaviors ofthe disorder, instead ofthe 
disorder as a whole. Some such behaviors include 
substance abuse and violence (Reid, & Gacono, 
2000). Long-term correctional settings seem to have 
little effect on symptoms ofAPD that are 
characterologically based, but they do seem to 
reduce criminal recidivism and drug abuse, which 
are two symptoms frequently observed in people 
with APD (Reid, & Gacono, 2000). Many studies 
focused on the reduction of such APD symptoms 
found that treatment completion in residential settings 
was the highest predictor of reduced drug use and 
post-treatment arrests (Messina, Wish, Hoffman, & 
Nemes, 2002; DeLeon, 2000, as cited in Messina 
et al., 2002). From these studies, and other 
residential treatment studies, it is unclear what factor 
within the treatment completion influences outcome 
the most though. Some factors to consider are 
patient compliance and the dose of each specific 
service received within the therapeutic community 
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(Messina, Wish, Hoffman, & Nemes, 2002). The 
most successful programs seem to combine 
consistent clinical and correctional techniques, and 
pattern their systems around a hierarchical privilege 
system, intolerance for rule breaking, and a strict 
encouragement to complete the program regardless 
of the length of the patients' sentence (Reid, 1981; 
Reid & Burke, 1989 as cited in Reid & Gacono, 
2000). 
At the time of their research, Reid and Gacono 
(2000) found only one study that illustrated any real 
success with treating adults with APD in a residential 
setting. This study, organized by Messina et al. 
(1999), reported that substance abusers with APD 
responded well to both standard and abbreviated 
residential treatments. Their success was measured 
by the reduction in their drug abuse and recidivism 
rates, but follow-up in this study was limited (Reid, 
& Gacono, 2000). 
Although this lack of hopeful research makes it 
easy to jump to the conclusion that people with APD 
are untreatable, it is necessary to look at other 
factors that may be influencing treatment outcome. 
For example, many studies report that the people 
being observed left treatment prematurely, which 
could have easily impacted their outcome negatively 
(Reid, & Gacono, 2000). It is also important to note 
that there is a general consensus among social 
scientists and treatment providers that the nature of 
APD makes it unlikely that anyone with the disorder 
will change their behavior (Messina, Wish, Hoffman, 
and Nemes, 2002). This pessimism amongst 
especially treatment providers could account for the 
treatment options already in effect not being 
successful. If treatment facilitators are going into 
their jobs with defeatist attitudes ofthe sort, 
treatment could be negatively affected. 
From the research reviewed, it seems that it is 
more likely to witness behavior change when 
antisocial behavior is treated in children and 
adolescents than when it is treated as a symptom of 
APD later in life. While treating APD, some 
evidence exists that certain symptoms, such as drug 
abuse and criminal behavior can be reduced, but the 
disorder as a whole appears unshakable. 
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Future Research and Conclusions 
In reviewing the evidence for and against 
different treatments for CD and APD, two ideas 
become obvious. The first idea is that all treatments 
that have been tested have produced mixed results, 
and because ofthis lack of consistent support, no 
one treatment can be accepted by clinicians and 
physicians. The second idea is that out of the 
treatments that have been tested, more promising 
results have surfaced for the treatment of CD, 
indicating that it is an easier disorder than APD to 
combat, and that early intervention should be a goal 
of physicians and clinicians handling children and 
adolescents with CD. In conclusion, research should 
be continued in the area of treating CD and APD, 
with a special focus on intervention to prevent APD 
from developing later in life. For those who already 
have an APD diagnosis, research should be 
continued regarding the use of psychotherapy for 
treatment, since this type ofresearch is still in its 
beginning phases (Kopta, Lueger, Saunders, & 
Howard, 1999). 
An issue to consider in future research designs is 
the fact that CD is so frequently comorbid with other 
disorders. Research shows that in most cases, 
treatment specificity is needed in cases where 
comorbidity exists, and that perhaps specific 
treatment programs for different disorders should be 
created (Rohde et al., 2004). Even in cases where 
comorbidity is not present, children and adolescents 
with CD respond so differently to treatment options 
that it may be necessary for psychotherapists to 
design treatment programs on a case-by-case basis, 
which is problematic because within their training, 
there is a push towards standardized treatment 
(Chambless, & 011endick, 2001). In regards to 
treating APD, society should first work to obliterate 
the negative connotation that is attached to the 
disorder. People with this disorder are often viewed 
as "morally deranged," and by labeling them as so, 
we are perhaps implying that their immorality makes 
them undeserving oftreatment. It is possible that this 
perspective may be blocking us from taking steps 
forward in identifying an effective treatment for APD 
(Smith, 1999). Since it is estimated that so many 
crimes are committed by people with APD, the 
disorder obviously presents a huge social problem 
that needs serious attention and further research 
devoted to it (Walker, Thomas, & Allen, 2003). 
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